Table 5 Secondary outcomes at 30 days after surgery
All patients | Mechanical valve | No mechanical valve | ||||
|---|---|---|---|---|---|---|
N = 411 | N = 257 | N = 154 | ||||
Secondary outcomes - no. (%) | ||||||
Clinically significant hematoma | 24 | 5.8% | 18 | 7.0% | 6 | 3.9% |
Hematoma prolonging hospitalization | 24 | 5.8% | 18 | 7.0% | 6 | 3.9% |
Hematoma requiring additional interruption of anti-coagulation | 15 | 3.7% | 9 | 3.5% | 6 | 3.9% |
Hematoma requiring evacuation | 6 | 1.5% | 4 | 1.6% | 2 | 1.3% |
Pneumothorax | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Hemothorax | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Cardiac tamponade | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Lead dislodgement | 4 | 1.0% | 3 | 1.2% | 1 | 0.7% |
Infection related to device system | 4 | 1.0% | 3 | 1.2% | 1 | 0.7% |
Myocardial infarction | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Major bleeding unrelated to CIED | 2 | 0.5% | 2 | 0.8% | 0 | 0.0% |